These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3323617)

  • 21. The relationship between body weight and blood pressure.
    Staessen J; Fagard R; Amery A
    J Hum Hypertens; 1988 Dec; 2(4):207-17. PubMed ID: 3070038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of genetic factors on selected indicators of the activity of the sympathoadrenal system and the renin-angiotensin-aldosterone system in twins.
    Jedrusik P; Januszewicz A; Busjahn A; Wocial B; Ignatowska-Switalska H; Strelau J; C Luft F; Januszewicz W
    Kardiol Pol; 2004 Nov; 61(11):423-9; discussion 430. PubMed ID: 15883590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Age-related changes in the renin-angiotensin-aldosterone system and the sympathetic nervous system in patients with essential hypertension].
    Nami R; Martinelli M; Panza F; Pavese G; Carletti F; Buracchi P; Lucani B; Pazzaglia A; Saia F; Gennari C
    Minerva Cardioangiol; 1993 Sep; 41(9):387-95. PubMed ID: 8259235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects.
    Dessì-Fulgheri P; Sarzani R; Rappelli A
    J Nephrol; 1998; 11(6):296-9. PubMed ID: 10048495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Various neurohumoral aspects of hemodynamic changes in patients with hypertension after correction of electrolyte disorders].
    Isazade GM; Gadzhiev RF; Bakhshaliev AB
    Sov Med; 1991; (8):13-6. PubMed ID: 1763349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of hypertension in obese patients].
    Comte-Perret S; Giusti V; Wuerzner G
    Rev Med Suisse; 2013 Sep; 9(397):1622, 1624-6. PubMed ID: 24073473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in the functional activity of the sympathetico-adrenal system after correction of electrolyte metabolism in patients with hypertension].
    Bakhshaliev AV; Gadzhiev RF
    Klin Med (Mosk); 1989 May; 67(5):64-7. PubMed ID: 2770212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Obesity-related hypertension].
    Dorresteijn JA; Visseren FL; van den Meiracker AH; Spiering W
    Ned Tijdschr Geneeskd; 2011; 154():A1945. PubMed ID: 21418695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenesis of essential hypertension.
    Ferriss JB
    Invest Cell Pathol; 1978; 1(2):171-97. PubMed ID: 401333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Aldosterone in Obesity-Related Hypertension.
    Kawarazaki W; Fujita T
    Am J Hypertens; 2016 Apr; 29(4):415-23. PubMed ID: 26927805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Etiopathogenic factors of arterial hypertension].
    Pérez-Olea J
    Rev Med Chil; 1992 Jun; 120(6):674-9. PubMed ID: 1341800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium and obesity in the pathogenesis of hypertension.
    Reisin E
    Am J Hypertens; 1990 Feb; 3(2):164-7. PubMed ID: 2155002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms in obesity-related hypertension: role of insulin and catecholamines.
    Krieger DR; Landsberg L
    Am J Hypertens; 1988 Jan; 1(1):84-90. PubMed ID: 3285861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity and hypertension: epidemiology, mechanisms, treatment.
    Berchtold P; Sims EA; Horton ES; Berger M
    Biomed Pharmacother; 1983; 37(6):251-8. PubMed ID: 6367845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of elevated blood pressure in obesity-related hypertension].
    Aoi W
    Nihon Rinsho; 1992 May; 50 Suppl():420-5. PubMed ID: 1512980
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors that influence the risk of hypertension in obese individuals.
    Coatmellec-Taglioni G; Ribière C
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity.
    Hall JE
    Hypertension; 1994 Mar; 23(3):381-94. PubMed ID: 8125566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of obesity hypertension.
    Hall JE
    Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of weight reduction on arterial pressure.
    Reisin E; Frohlich ED
    J Chronic Dis; 1982; 35(12):887-91. PubMed ID: 7174770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.